Document Type
Patent
Publication Date
March 2014
Patent Number
8673867
Abstract
This application relates to combination therapies including triciribine compounds and epidermal growth factor receptor inhibitor compounds, particularly erlotinib-like compounds and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
Application Number
13/453,789
Recommended Citation
Cheng, Jin Q. and Sebti, Said M., "Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof" (2014). USF Patents. 94.
https://digitalcommons.usf.edu/usf_patents/94
Assignees
University of South Florida
Filing Date
04/23/2012
Primary/U.S. Class
514/43